Nisa Investment Advisors
ACET icon

Nisa Investment Advisors’s Adicet Bio ACET Stock Holding History

Nisa Investment Advisors’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6
Closed -$121 – 2639
2023
Q3 		$121 Buy
+6
New +$212 ﹤0.01% 2721
2023
Q2 		– Sell
-1
Closed – – 2801
2023
Q1 		$0 Buy
+1
New +$125 ﹤0.01% 2509
2022
Q4 		– Sell
-2
Closed – – 2567
2022
Q3 		$0 Buy
+2
New +$508 ﹤0.01% 2571
2022
Q2 		– Sell
-925
Closed -$296K – 2364
2022
Q1 		$296K Buy
+925
New +$213K ﹤0.01% 1232

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nisa Investment Advisors's ACET Position: Q4 2023 in Review

Nisa Investment Advisors sold out of Adicet Bio (ACET) in Q4 2023, closing a stake of 6 shares — an estimated $121 sold.

Nisa Investment Advisors first reported a position in ACET in Q1 2022 and held it in 4 quarters. The position peaked at $296K in Q1 2022. 76 funds tracked by Wall St. Rank hold ACET as of Q4 2023.

  • Nisa Investment Advisors reported no remaining Adicet Bio position as of Q4 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 6 Adicet Bio shares in Q4 2023, an estimated $121.
  • Nisa Investment Advisors first reported a position in Adicet Bio in Q1 2022 and held it in 4 quarters.
  • Nisa Investment Advisors's Adicet Bio position peaked at $296K in Q1 2022.
  • 76 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2023.

Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.